Raymond James Financial
RVMD icon

Raymond James Financial’s Revolution Medicines RVMD Stock Holding History

Raymond James Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Sell
137,160
-107,014
-44% -$10.8M ﹤0.01% 1780
2025
Q4 		$19.4M Sell
244,174
-33,986
-12% -$2.23M 0.01% 1459
2025
Q3 		$13M Sell
278,160
-17,059
-6% -$668K ﹤0.01% 1724
2025
Q2 		$10.9M Sell
295,219
-8,398
-3% -$323K ﹤0.01% 1802
2025
Q1 		$10.7M Sell
303,617
-17,994
-6% -$730K ﹤0.01% 1760
2024
Q4 		$14.1M Buy
+321,611
New +$16.2M 0.01% 1584

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Raymond James Financial's RVMD Position: Q1 2026 in Review

Raymond James Financial reduced its Revolution Medicines (RVMD) stake by 44% in Q1 2026, selling an estimated $10.8M and leaving 137,160 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Raymond James Financial first reported a position in RVMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $19.4M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Raymond James Financial held 137,160 shares of Revolution Medicines worth $13.3M as of Q1 2026.
  • Raymond James Financial sold 107,014 Revolution Medicines shares in Q1 2026, an estimated $10.8M.
  • Revolution Medicines made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1780 holding.
  • Raymond James Financial first reported a position in Revolution Medicines in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Revolution Medicines position peaked at $19.4M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.